Dual-Device Neuromodulation in Epilepsy

AdultPediatric
Written By Rodrigo Silva

Freund B, Grewal SS, Middlebrooks EH, Moniz-Garcia D, Feyissa AM, Tatum WO.
World Neurosurg. 2022 Feb 18;S1878-8750(22)00205-4
https://doi.org/10.1016/j.wneu.2022.02.057

Have a look at this new publication by Freund et al. 2022 that #retrospectively analyses trends in the usage of dual #neurostimulation (active vagus nerve stimulation, #VNS, in combination with responsive neurostimulation, #RNS, or deep brain stimulation, #DBS) as a treatment for drug resistant epilepsy (#DRE), based on information from the Mayo Clinic database in Florida (1998-2021).

The study identified prior VNS effectiveness to be more common in patients undergoing DBS surgery. Furthermore, invasive electroencephalographic (#EEG) monitoring was more frequently observed for the patients receiving RNS therapy. The simultaneous use of two different neurostimulation therapies appeared to be safe.

 
 
Rodrigo Silva
Previous

Automated detection of absence seizures using a wearable electroencephalographic device: a phase 3 validation study and feasibility of automated behavioral testing.
Next

ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy.